Eterobarb
Eterobarb is a barbiturate derivative that has been used in the past as a sedative and hypnotic agent. It is known for its ability to depress the central nervous system, leading to effects such as sedation, anxiolysis, and hypnosis.
Chemical Structure and Properties[edit]
Eterobarb belongs to the class of barbiturates, which are derivatives of barbituric acid. The chemical structure of Eterobarb includes a pyrimidine ring fused with a urea moiety, characteristic of barbiturates. This structure allows it to interact with the gamma-aminobutyric acid (GABA) receptors in the brain, enhancing the inhibitory effects of GABA and leading to its sedative properties.
Pharmacology[edit]
Eterobarb acts primarily by binding to the GABA_A receptors in the central nervous system. This binding increases the duration of the chloride ion channel opening, leading to hyperpolarization of the neuron and a decrease in neuronal excitability. The result is a calming effect on the brain, which can induce sleep and reduce anxiety.
Medical Uses[edit]
Eterobarb was historically used for its sedative and hypnotic properties. It was prescribed for the treatment of insomnia, anxiety disorders, and as a pre-anesthetic agent. However, due to the development of safer and more effective medications, its use has significantly declined.
Side Effects and Risks[edit]
The use of Eterobarb, like other barbiturates, is associated with several side effects. These can include drowsiness, dizziness, nausea, and headache. More severe risks involve respiratory depression, dependence, and withdrawal symptoms. Overdose of Eterobarb can be fatal, leading to coma and death.
Regulation and Legal Status[edit]
Due to its potential for abuse and dependence, Eterobarb is classified as a controlled substance in many countries. Its medical use is highly restricted, and it is generally only available through special prescription.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
